34
Participants
Start Date
May 31, 2001
Primary Completion Date
January 31, 2005
Study Completion Date
May 31, 2011
Celecoxib
Selective inhibition of COX-2 without significant cyclooxygenase-1 (COX-1) inhibition
Placebo
Portland VA Medical Center, Portland
OHSU Knight Cancer Institute, Portland
Collaborators (1)
Pfizer
INDUSTRY
OHSU Knight Cancer Institute
OTHER